These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 2170064)
1. Serum immunoreactive prolyl 4-hydroxylase as a specific marker of hepatocellular necrosis. Nagai Y; Toda G Clin Chim Acta; 1990 Sep; 190(1-2):109-10. PubMed ID: 2170064 [No Abstract] [Full Text] [Related]
2. Studies on serum immunoreactive prolyl 4-hydroxylase in liver diseases--its elevation both in hepatocellular damage and cholestatic diseases. Nagai Y; Yoshiba M Clin Chim Acta; 1988 Jun; 175(1):27-36. PubMed ID: 2844441 [TBL] [Abstract][Full Text] [Related]
3. Are serum type III procollagen and prolyl hydroxylase useful as noninvasive markers of liver disease in patients with cystic fibrosis? Leonardi S; Giambusso F; Sciuto C; Castiglione S; Castiglione N; La Rosa M J Pediatr Gastroenterol Nutr; 1998 Nov; 27(5):603-5. PubMed ID: 9822332 [No Abstract] [Full Text] [Related]
4. Selectivity of serum immunoreactive prolyl 4-hydroxylase as a marker for hepatic necrosis. Nagai Y; Kato M; Toda G J Gastroenterol Hepatol; 1992; 7(3):253-6. PubMed ID: 1319223 [TBL] [Abstract][Full Text] [Related]
8. Human prolyl-hydroxylase: only a marker of hepatic damage? Tamaro G; Pozzato G; Moretti M Int J Clin Lab Res; 1993; 23(4):228. PubMed ID: 8123880 [No Abstract] [Full Text] [Related]
9. Human prolyl hydroxylase. Purification, radioimmunoassay and clinical studies in liver diseases. Nagai Y; Oka H Gastroenterol Jpn; 1985 Feb; 20(1):53-64. PubMed ID: 2991066 [TBL] [Abstract][Full Text] [Related]
10. Effect of hepatic injury on prolyl 3-hydroxylase and 4-hydroxylase activities in rat liver and on immunoreactive prolyl 4-hydroxylase concentrations in the liver and serum. Risteli J; Tuderman L; Tryggvason K; Kivirikko KI Biochem J; 1978 Jan; 170(1):129-35. PubMed ID: 204299 [TBL] [Abstract][Full Text] [Related]
12. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin. Murawaki Y; Kusakabe Y; Hirayama C Hepatology; 1991 Dec; 14(6):1167-73. PubMed ID: 1683640 [TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of the determination of serum immunoreactive prolyl hydroxylase (SIRPH) in hepatic fibrosis]. Suzuki H; Suzuki M; Okabe K; Uchikoshi T Nihon Shokakibyo Gakkai Zasshi; 1987 Jun; 84(6):1265-71. PubMed ID: 2822984 [No Abstract] [Full Text] [Related]
14. A sandwich immunoassay for human prolyl 4-hydroxylase using monoclonal antibody. Yoshida S; Bai Y; Muragaki Y; Ooshima A; Inada K; Nagai Y; Obata K; Iwata K; Hashida S; Ishikawa E Clin Chim Acta; 1986 Oct; 160(1):37-46. PubMed ID: 3021363 [TBL] [Abstract][Full Text] [Related]
15. [Significance of prolyl hydroxylase analysis in clinical tests]. Yamada S; Kawasaki H Nihon Rinsho; 1989 Dec; 48 Suppl():321-3. PubMed ID: 2560079 [No Abstract] [Full Text] [Related]
16. Immunoreactive prolyl hydroxylase protein and galactosylhydroxylysyl glucosyltransferase activity in breast tissues and sera of patients with primary breast cancer. Bolarin DM Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):493-502. PubMed ID: 6304825 [TBL] [Abstract][Full Text] [Related]